Building Resilience and Precision in Pharma Development

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com

Each new chapter in pharmaceutical innovation underscores a simple truth: the path from molecule to medicine is never linear. Scientific discovery, technological evolution, and market demands constantly reshape the landscape, requiring both agility and vision from every stakeholder. This issue of Pharmaceutical Technology® captures the state of that journey, one that is as much about mastering fundamentals as it is about embracing new tools and approaches.

Our cover story, “The Evolving Science Behind Formulation Development,” explores strategies across the drug product lifecycle. Vaibhav Sihorkar, PhD, of Aragen Life Sciences, offers insights into problem solving, the role of digital tools, and how geopolitical change is influencing formulation decisions from a CRDMO’s perspective. The complex area of drug formulation is further explored in Cynthia Challener’s “Personalized and Patient-Centric Administration of Oral Medicines,” which highlights how individualized therapies are moving forward despite the challenges of scalability and regulation.

Ensuring product quality remains at the forefront. In our Ask the Expert feature, Michelle Heiter and Susan J. Schniepp outline best practices for implementing contamination control strategies that safeguard patient safety and regulatory compliance. Meanwhile, the Pharma Fundamentals article by Evonne Brennan reinforces the essential skills professionals need to thrive in this rapidly changing field.

At the critical stage of technology transfer, “Emerging Tools, Integrated Controls Impact Tech Transfer” highlights how smarter systems can streamline the transition from lab to production. In advanced therapies, “Optimizing Testing in Cell and Gene Therapy” underscores the need for agile, compliant testing methods that can keep pace with accelerated development timelines. On the manufacturing front, Susan Haigney’s “Keys to Navigating the Complex Drug Supply Chain” shows how digital tools help manufacturers adapt to ongoing global volatility.

As a whole, this issue reveals an industry strengthening its foundation while embracing innovation. Success now demands not just advanced tools and processes, but collaboration, resilience, and a focus on improving outcomes for patients worldwide.

About the author

Mike Hennessy Jr is Chairman and CEO of MJH Life Sciences®.

Article details

Pharmaceutical Technology®
Vol. 49, No. 7
September 2025
Page: 8

Citation

When referring to this article, please cite it has Hennessy, M. Building Resilience and Precision in Pharma Development. Pharmaceutical Technology 2025 49 (7).